From Aug. 21, 2018, through June 26, 2019, the clinic billed CMS for the implantation of 41 periarticular stimulation devices, which is an electroacupuncture system.
CMS reimbursed the practice $177,051 for the procedures. However, CMS does not reimburse providers for acupuncture devices such as periarticular stimulation or reimburse periarticular stimulation devices as neurostimulators.
“Falsely submitting claims for non-covered services robs from the Medicare program and thereby deprives those in need from vital resources,” U.S. Attorney Stephen J. Cox said in a news release. “Recovery of improperly paid reimbursements is critical to the long-term sustainability of the Medicare program, and we will do everything we can to ensure that any false claim is quickly recovered.”
More articles on legal and regulatory issues:
Connecticut hospital faces class action for allegedly reusing insulin pens
Patient recruiter convicted in $2.8M telemedicine scheme
Former employee sues Alliance Healthcare Services over claims of unequal pay, whistleblower retaliation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
